BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 32053679)

  • 21. Same day HIV diagnosis and antiretroviral therapy initiation affects retention in Option B+ prevention of mother-to-child transmission services at antenatal care in Zomba District, Malawi.
    Chan AK; Kanike E; Bedell R; Mayuni I; Manyera R; Mlotha W; Harries AD; van Oosterhout JJ; van Lettow M
    J Int AIDS Soc; 2016; 19(1):20672. PubMed ID: 26976377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilot programme for the rapid initiation of antiretroviral therapy in pregnancy in Cape Town, South Africa.
    Myer L; Zulliger R; Black S; Pienaar D; Bekker LG
    AIDS Care; 2012; 24(8):986-92. PubMed ID: 22519561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated prevention of mother-to-child HIV transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central Nigeria: a cluster-randomised controlled trial.
    Aliyu MH; Blevins M; Audet CM; Kalish M; Gebi UI; Onwujekwe O; Lindegren ML; Shepherd BE; Wester CW; Vermund SH
    Lancet HIV; 2016 May; 3(5):e202-11. PubMed ID: 27126487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of suboptimal adherence and elevated HIV viral load in pregnant women already on antiretroviral therapy when entering antenatal care in Cape Town, South Africa.
    Brittain K; Remien RH; Mellins CA; Phillips TK; Zerbe A; Abrams EJ; Myer L
    AIDS Care; 2018 Dec; 30(12):1517-1523. PubMed ID: 30047287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors Associated With Peripartum Virologic Suppression in Eastern Cape Province, South Africa: A Retrospective Cross-Sectional Analysis.
    Adeniyi OV; Obi CL; Goon DT; Iweriebor B; Selanto-Chairman N; Carty C; Avramovic G; Ajayi AI; Lambert J; Okoh A
    Clin Infect Dis; 2021 Nov; 73(10):1750-1758. PubMed ID: 33677576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of community-based support for pregnant women living with HIV: a cohort study in South Africa.
    Fatti G; Shaikh N; Eley B; Grimwood A
    AIDS Care; 2016; 28 Suppl 1(sup1):114-8. PubMed ID: 26922939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal timing of viral load monitoring during pregnancy to predict viraemia at delivery in HIV-infected women initiating ART in South Africa: a simulation study.
    Lesosky M; Glass T; Mukonda E; Hsiao NY; Abrams EJ; Myer L
    J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29171179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.
    Kakehasi FM; Tupinambás U; Cleto S; Aleixo A; Lin E; Melo VH; Aguiar RA; Pinto JA
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1515-20. PubMed ID: 18160009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cohort profile: the Hlabisa pregnancy cohort, KwaZulu-Natal, South Africa.
    Chetty T; Thorne C; Tanser F; Bärnighausen T; Coutsoudis A
    BMJ Open; 2016 Oct; 6(10):e012088. PubMed ID: 27798004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa.
    Bor J; Fox MP; Rosen S; Venkataramani A; Tanser F; Pillay D; Bärnighausen T
    PLoS Med; 2017 Nov; 14(11):e1002463. PubMed ID: 29182641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4, viral load response, and adherence among antiretroviral-naive breast-feeding women receiving triple antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV in Kisumu, Kenya.
    Okonji JA; Zeh C; Weidle PJ; Williamson J; Akoth B; Masaba RO; Fowler MG; Thomas TK
    J Acquir Immune Defic Syndr; 2012 Oct; 61(2):249-57. PubMed ID: 22692094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique.
    Rupérez M; Noguera-Julian M; González R; Maculuve S; Bellido R; Vala A; Rodríguez C; Sevene E; Paredes R; Menéndez C
    PLoS One; 2018; 13(5):e0196451. PubMed ID: 29742132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retention and viral suppression of newly diagnosed and known HIV positive pregnant women on Option B+ in Western Kenya.
    Akama E; Nimz A; Blat C; Moghadassi M; Oyaro P; Maloba M; Cohen CR; Bukusi EA; Abuogi LL
    AIDS Care; 2019 Mar; 31(3):333-339. PubMed ID: 30261742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of plasma viral-load monitoring and the prevention of mother-to-child transmission of HIV-1 in three health facilities of the Littoral region of Cameroon.
    Kafack EVF; Fokam J; Nana TN; Saniotis A; Halle-Ekane GE
    PLoS One; 2022; 17(11):e0277271. PubMed ID: 36342923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterizing Viral Load Burden Among HIV-Infected Women Around the Time of Delivery: Findings From Four Tertiary Obstetric Units in Gauteng, South Africa.
    Moyo F; Haeri Mazanderani A; Murray T; Technau KG; Carmona S; Kufa T; Sherman GG
    J Acquir Immune Defic Syndr; 2020 Apr; 83(4):390-396. PubMed ID: 31914002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho Study.
    Gill MM; Hoffman HJ; Bobrow EA; Mugwaneza P; Ndatimana D; Ndayisaba GF; Baribwira C; Guay L; Asiimwe A
    PLoS One; 2016; 11(12):e0168671. PubMed ID: 28006001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Achieving maternal viral load suppression for elimination of mother-to-child transmission of HIV in South Africa.
    Moyo F; Mazanderani AH; Murray T; Sherman GG; Kufa T
    AIDS; 2021 Feb; 35(2):307-316. PubMed ID: 33394673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of vertical transmission of HIV in Khayelitsha, South Africa: A contemporary review of services after 20 years.
    Phelanyane FM; Heekes A; Smith M; Jennings K; Mudaly V; Pieters P; Arendse J; Kariem S; Coetzee D; Boulle A; Kalk E
    S Afr Med J; 2023 Oct; 113(10):14-19. PubMed ID: 37881910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Previous antiretroviral therapy for prevention of mother-to-child transmission of HIV does not hamper the initial response to PI-based multitherapy during subsequent pregnancy.
    Briand N; Mandelbrot L; Blanche S; Tubiana R; Faye A; Dollfus C; Le Chenadec J; Benhammou V; Rouzioux C; Warszawski J;
    J Acquir Immune Defic Syndr; 2011 Jun; 57(2):126-35. PubMed ID: 21436712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi.
    Weigel R; Hosseinipour MC; Feldacker C; Gareta D; Tweya H; Chiwoko J; Gumulira J; Kalulu M; Mofolo I; Kamanga E; Mwale G; Kadzakumanja A; Jere E; Phiri S
    Trop Med Int Health; 2012 Jun; 17(6):751-9. PubMed ID: 22487553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.